Express Scripts (ESRX) 75.91 $ESRX
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016
PR Newswire - Fri Jun 10, 11:38AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ: ESRX) securities between February 24, 2015 through March 21, 2016.
ESRX: 75.91 (-1.02)
UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Express Scripts Holding Company To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
BusinessWire - Wed Jun 08, 1:35PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts" or the "Company"
common stock during the period between February 24, 2015 to March 21, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 5, 2016 to seek appointment as lead plaintiff.
ESRX: 75.91 (-1.02)
Express Scripts Rises 1.81% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 08, 12:41PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.05 to a high of $77.25. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $76.49 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 75.91 (-1.02)
Look for Shares of Express Scripts to Potentially Pullback after Yesterday's 1.81% Rise
Comtex SmarTrend(R) - Wed Jun 08, 12:39PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.05 to a high of $77.25. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $76.49 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 75.91 (-1.02)
JULY 5 DEADLINE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Jun 08, 12:03PM CDT
IRVINE, CA / ACCESSWIRE / June 8, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
ESRX: 75.91 (-1.02)
Next Resistance Level for Express Scripts (ESRX) is $76.77
Comtex SmarTrend(R) - Wed Jun 08, 9:24AM CDT
Shares of Express Scripts (NASDAQ:ESRX) opened today above their pivot of $76.03 and have already reached the first level of resistance at $76.30. Should the shares continue to rise, the resistance pivots of $76.77 and $77.51 will be of interest.
ESRX: 75.91 (-1.02)
Glancy Prongay & Murray Commences Investigation on Behalf of Express Scripts Holding Company Investors
BusinessWire - Mon Jun 06, 1:41PM CDT
Glancy Prongay & Murray LLP ("GPM" announces an investigation on behalf of investors of Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX) concerning the Company and its officers' possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of injured investors.
ESRX: 75.91 (-1.02)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Express Scripts Holding Company of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016
BusinessWire - Mon Jun 06, 12:17PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ESRX: 75.91 (-1.02)
IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation of Express Scripts Holding Company and Advises Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 03, 9:34PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 3, 2016 / Lundin Law PC announces it is investigating claims against Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX) concerning possible violations of federal securities laws. The investigation is related to allegations that certain statements issued by Express Scripts were false and misleading and/or failed to disclose material information regarding the Company's financial performance.
ESRX: 75.91 (-1.02)
EXPRESS SCRIPTS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Express Scripts Holding Company
BusinessWire - Fri Jun 03, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Express Scripts Holding Company (NasdaqGS: ESRX), if they purchased the Company's securities between February 24, 2015 and March 21, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York.
ESRX: 75.91 (-1.02)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Express Scripts Holding Company - ESRX
GlobeNewswire - Fri Jun 03, 1:50PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Express Scripts Holding Company securities (NASDAQ:ESRX) from February 24, 2015 through March 21, 2016, both dates inclusive (the "Class Period". The lawsuit seeks to recover damages for Express Scripts investors under the federal securities laws.
ESRX: 75.91 (-1.02)
Biosimilars, PCSK9s, Value-Based Care Among Hot-Button Topics Tracked in New AIS Book
PRWeb - Fri Jun 03, 5:06AM CDT
Recently published by Atlantic Information Services, Inc. (AIS), Specialty Pharmacy Trends and Strategies: 2016-2017 Edition, tracks hot-button issues in the specialty pharmacy industry that will affect PBMs and insurers in 2016 and beyond, including the rise of biosimilars, PCSK9s and value-based initiatives: According to reporting in Specialty Pharmacy Trends and Strategies, Express Scripts, Inc. has estimated that Zarxio -- the first biosimilar approved by the Food and Drug Administration -- has the potential to save U.S. patients and payers $5.7 billion between 2014 and 2024 and additional drugs in the biosimilar pipeline could save an estimated $250 billion in savings over the next 10 years. But a lawsuit (Amgen Inc., Amgen Manufacturing Limited v. Sandoz Inc., No. 15-1499) raised several questions, including patent issues based on the language of the Biologics Price Competition and Innovation Act of the Affordable Care Act, and delayed Zarxio's launch. The book tracks the lawsuit and its implications, as well as the biosimilar space as whole, and provides historical background and future insight. Specialty Pharmacy Trends and Strategies also follows the impact of cholesterol-lowering PCSK9 inhibitors hitting the market, boasting costs $5,000 higher than industry insiders expected and causing pharmacy benefit managers to either balk at coverage or negotiate pay-for-performance deals with manufacturers. Cardiologists are excited for their potential, but health plans and PBMs have shown reluctance to fully embrace these super-statins. The book charts the implications for specialty pharmacy spend. One way payers are attempting to control costs of new drug innovations is the use of value-based initiatives, from bundled payments and other strategies in the oncology space to the use of quality-based pharmacy networks to drive better outcomes and thus lower prices. Specialty Pharmacy Trends and Strategies follows pilots and proposals undertaken by insurers, PBMs and the federal government to tie reimbursement and benefit design to more positive results for patients and payers.
ESRX: 75.91 (-1.02), AMGN: 154.78 (-2.00)
DEADLINE APPROACHING: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jun 02, 11:12AM CDT
IRVINE, CA / ACCESSWIRE / June 2, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
ESRX: 75.91 (-1.02)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016
BusinessWire - Wed Jun 01, 10:26AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ: ESRX) securities between February 24, 2015 through March 21, 2016.
ESRX: 75.91 (-1.02)
Express Scripts Holding Company to Present at Upcoming Conferences
PR Newswire - Tue May 31, 4:11PM CDT
Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the following conferences:
ESRX: 75.91 (-1.02)
SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm
BusinessWire - Tue May 31, 3:12PM CDT
Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (Nasdaq: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
ESRX: 75.91 (-1.02)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Express Scripts Holding Company to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - ESRX
GlobeNewswire - Sun May 29, 11:40AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Express Scripts Holding Company (Nasdaq:ESRX) ("Express Scripts" or the "Company" common stock during the period between February 24, 2015 to March 21, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 5, 2016 to seek appointment as lead plaintiff.
ESRX: 75.91 (-1.02)
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm
BusinessWire - Fri May 27, 6:48PM CDT
Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (Nasdaq: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
ESRX: 75.91 (-1.02)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016 -- ESRX
GlobeNewswire - Fri May 27, 11:27AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ:ESRX) securities between February 24, 2015 through March 21, 2016.
ESRX: 75.91 (-1.02)
Safirstein Metcalf LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Express Scripts Holding Company Securities Case- ESRX
GlobeNewswire - Wed May 25, 8:25AM CDT
Safirstein Metcalf LLP announces that a class action has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ:ESRX) stock or options between February 24, 2015 and March 21, 2016 (the "Class Period".
ESRX: 75.91 (-1.02)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016
PR Newswire - Fri Jun 10, 11:38AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ: ESRX) securities between February 24, 2015 through March 21, 2016.
ESRX: 75.91 (-1.02)
UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Express Scripts Holding Company To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
BusinessWire - Wed Jun 08, 1:35PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Express Scripts Holding Company (Nasdaq: ESRX) ("Express Scripts" or the "Company"
common stock during the period between February 24, 2015 to March 21, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 5, 2016 to seek appointment as lead plaintiff. ESRX: 75.91 (-1.02)
Express Scripts Rises 1.81% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 08, 12:41PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.05 to a high of $77.25. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $76.49 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 75.91 (-1.02)
Look for Shares of Express Scripts to Potentially Pullback after Yesterday's 1.81% Rise
Comtex SmarTrend(R) - Wed Jun 08, 12:39PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $76.05 to a high of $77.25. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $76.49 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 75.91 (-1.02)
JULY 5 DEADLINE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Jun 08, 12:03PM CDT
IRVINE, CA / ACCESSWIRE / June 8, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. ESRX: 75.91 (-1.02)
Next Resistance Level for Express Scripts (ESRX) is $76.77
Comtex SmarTrend(R) - Wed Jun 08, 9:24AM CDT
Shares of Express Scripts (NASDAQ:ESRX) opened today above their pivot of $76.03 and have already reached the first level of resistance at $76.30. Should the shares continue to rise, the resistance pivots of $76.77 and $77.51 will be of interest.
ESRX: 75.91 (-1.02)
Glancy Prongay & Murray Commences Investigation on Behalf of Express Scripts Holding Company Investors
BusinessWire - Mon Jun 06, 1:41PM CDT
Glancy Prongay & Murray LLP ("GPM"
announces an investigation on behalf of investors of Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX) concerning the Company and its officers' possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of injured investors. ESRX: 75.91 (-1.02)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Express Scripts Holding Company of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 5, 2016
BusinessWire - Mon Jun 06, 12:17PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ESRX: 75.91 (-1.02)
IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Investigation of Express Scripts Holding Company and Advises Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 03, 9:34PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 3, 2016 / Lundin Law PC announces it is investigating claims against Express Scripts Holding Company ("Express Scripts" or the "Company"
(NASDAQ: ESRX) concerning possible violations of federal securities laws. The investigation is related to allegations that certain statements issued by Express Scripts were false and misleading and/or failed to disclose material information regarding the Company's financial performance. ESRX: 75.91 (-1.02)
EXPRESS SCRIPTS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Express Scripts Holding Company
BusinessWire - Fri Jun 03, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Express Scripts Holding Company (NasdaqGS: ESRX), if they purchased the Company's securities between February 24, 2015 and March 21, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Southern District of New York. ESRX: 75.91 (-1.02)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Express Scripts Holding Company - ESRX
GlobeNewswire - Fri Jun 03, 1:50PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Express Scripts Holding Company securities (NASDAQ:ESRX) from February 24, 2015 through March 21, 2016, both dates inclusive (the "Class Period"
. The lawsuit seeks to recover damages for Express Scripts investors under the federal securities laws. ESRX: 75.91 (-1.02)
Biosimilars, PCSK9s, Value-Based Care Among Hot-Button Topics Tracked in New AIS Book
PRWeb - Fri Jun 03, 5:06AM CDT
Recently published by Atlantic Information Services, Inc. (AIS), Specialty Pharmacy Trends and Strategies: 2016-2017 Edition, tracks hot-button issues in the specialty pharmacy industry that will affect PBMs and insurers in 2016 and beyond, including the rise of biosimilars, PCSK9s and value-based initiatives: According to reporting in Specialty Pharmacy Trends and Strategies, Express Scripts, Inc. has estimated that Zarxio -- the first biosimilar approved by the Food and Drug Administration -- has the potential to save U.S. patients and payers $5.7 billion between 2014 and 2024 and additional drugs in the biosimilar pipeline could save an estimated $250 billion in savings over the next 10 years. But a lawsuit (Amgen Inc., Amgen Manufacturing Limited v. Sandoz Inc., No. 15-1499) raised several questions, including patent issues based on the language of the Biologics Price Competition and Innovation Act of the Affordable Care Act, and delayed Zarxio's launch. The book tracks the lawsuit and its implications, as well as the biosimilar space as whole, and provides historical background and future insight. Specialty Pharmacy Trends and Strategies also follows the impact of cholesterol-lowering PCSK9 inhibitors hitting the market, boasting costs $5,000 higher than industry insiders expected and causing pharmacy benefit managers to either balk at coverage or negotiate pay-for-performance deals with manufacturers. Cardiologists are excited for their potential, but health plans and PBMs have shown reluctance to fully embrace these super-statins. The book charts the implications for specialty pharmacy spend. One way payers are attempting to control costs of new drug innovations is the use of value-based initiatives, from bundled payments and other strategies in the oncology space to the use of quality-based pharmacy networks to drive better outcomes and thus lower prices. Specialty Pharmacy Trends and Strategies follows pilots and proposals undertaken by insurers, PBMs and the federal government to tie reimbursement and benefit design to more positive results for patients and payers.
ESRX: 75.91 (-1.02), AMGN: 154.78 (-2.00)
DEADLINE APPROACHING: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jun 02, 11:12AM CDT
IRVINE, CA / ACCESSWIRE / June 2, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (NASDAQ: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. ESRX: 75.91 (-1.02)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016
BusinessWire - Wed Jun 01, 10:26AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ: ESRX) securities between February 24, 2015 through March 21, 2016.
ESRX: 75.91 (-1.02)
Express Scripts Holding Company to Present at Upcoming Conferences
PR Newswire - Tue May 31, 4:11PM CDT
Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the following conferences:
ESRX: 75.91 (-1.02)
SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm
BusinessWire - Tue May 31, 3:12PM CDT
Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (Nasdaq: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. ESRX: 75.91 (-1.02)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Express Scripts Holding Company to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - ESRX
GlobeNewswire - Sun May 29, 11:40AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Express Scripts Holding Company (Nasdaq:ESRX) ("Express Scripts" or the "Company"
common stock during the period between February 24, 2015 to March 21, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until July 5, 2016 to seek appointment as lead plaintiff. ESRX: 75.91 (-1.02)
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm
BusinessWire - Fri May 27, 6:48PM CDT
Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Express Scripts Holding Company ("Express Scripts" or the "Company" (Nasdaq: ESRX). Investors who purchased or otherwise acquired shares between February 24, 2015 and March 21, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. ESRX: 75.91 (-1.02)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Express Scripts Holding Company and a Lead Plaintiff Deadline of July 5, 2016 -- ESRX
GlobeNewswire - Fri May 27, 11:27AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Express Scripts Holding Company (NASDAQ:ESRX) securities between February 24, 2015 through March 21, 2016.
ESRX: 75.91 (-1.02)
Safirstein Metcalf LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Express Scripts Holding Company Securities Case- ESRX
GlobeNewswire - Wed May 25, 8:25AM CDT
Safirstein Metcalf LLP announces that a class action has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Express Scripts Holding Company ("Express Scripts" or the "Company"
(NASDAQ:ESRX) stock or options between February 24, 2015 and March 21, 2016 (the "Class Period". ESRX: 75.91 (-1.02)
